Liminal BioSciences Inc.
LMNL · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $703 | $434 | $372 | $491 |
| - Cash | $19,312 | $26,942 | $37,144 | $40,752 |
| + Debt | $1,207 | $1,357 | $1,487 | $1,564 |
| Enterprise Value | -$17,402 | -$25,151 | -$35,285 | -$38,697 |
| Revenue | $112 | $136 | $241 | $3 |
| % Growth | -17.6% | -43.6% | 7,933.3% | – |
| Gross Profit | $112 | $136 | $241 | $3 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$8,856 | -$7,115 | -$13,704 | -$10,079 |
| % Margin | -7,907.1% | -5,231.6% | -5,686.3% | -335,966.7% |
| Net Income | -$9,141 | -$7,648 | -$4,772 | $21,915 |
| % Margin | -8,161.6% | -5,623.5% | -1,980.1% | 730,500% |
| EPS Diluted | -2.94 | -2.46 | -1.54 | 7 |
| % Growth | -19.5% | -59.7% | -122% | – |
| Operating Cash Flow | -$7,779 | -$10,342 | -$6,299 | -$11,698 |
| Capital Expenditures | $0 | $0 | $19 | -$3 |
| Free Cash Flow | -$7,779 | -$10,342 | -$6,280 | -$11,701 |